Pancreatic expression of interferon-γ protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis

Nature Medicine

Volumn 6, Issue 6, 2000, Pages 693-697

  Horwitz, Marc S ^a   La Cava, Antonio ^a   Fine, Cody ^a   Rodriguez, Enrique ^a   Ilic, Alex ^a   Sarvetnick, Nora ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; COXSACKIE VIRUS B3; COXSACKIE VIRUS INFECTION; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; FEMALE; IMMUNOPATHOGENESIS; MOUSE; NONHUMAN; PANCREAS; PRIORITY JOURNAL; TRANSGENIC MOUSE; VIRUS MYOCARDITIS; VIRUS PATHOGENESIS;

ANIMALS; AUTOANTIBODIES; COXSACKIEVIRUS INFECTIONS; DISEASE MODELS, ANIMAL; ENTEROVIRUS B, HUMAN; GENE EXPRESSION; HEART; HELA CELLS; HUMANS; INTERFERON TYPE II; MICE; MICE, INBRED NOD; MICE, TRANSGENIC; MYOCARDITIS; MYOCARDIUM; MYOSINS; PANCREAS;

ANIMALIA; COXSACKIEVIRUS; COXSACKIEVIRUS B; MUS MUSCULUS; RODENTIA;

EID: 0034086692     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/76277     Document Type: Article

References (24)

1. Felker, G.M., Hu, W., Hare, J.M., Hruban, R.H., Baughman, K.L. & Kasper, E.K. The spectrum of dilated cardiomyopathy. The Johns Hopkins experience with 1,278 patients. Medicine 78, 270-83 (1999).
2. Martino, T.A., Liu, P. & Sole, M.J. Viral infection and the pathogenesis of dilated cardiomyopathy. Circ. Res. 74, 182-188 (1994).
3. Baboonian, C., Davies, M.J., Booth, J.C. & McKenna, W.J. Coxsackie B viruses and human heart disease. Curr. Top. Microbiol. Immunol. 223, 31-52 (1997).
4. Baboonian, C. & Treasure, T. Meta-analysis of the association of enteroviruses with human heart disease. Heart 78, 539-543 (1997).
5. Rose, N.R. & Hill, S.L. The pathogenesis of postinfectious myocarditis. Clin. Immunol. Immunopathol. 80, S92-S99 (1996).
6. Godman, G.C., Bunting, H. & Melnick, J.L. The Histopathology of coxsackievirus infection in mice. I Morphologic observations with four different viral types. Am. J. Pathol 28, 223-258 (1952).
7. Chow, L.H., Beisel, K.W. & McManus, B.M. Enteroviral infection of mice with severe combined immunodeficiency. Evidence for direct viral pathogenesis of myocardial injury. Lab. Invest. 66, 24-31 (1992).
8. McManus, B.M. et al. Direct myocardial injury by enterovirus: a central role in the evolution of murine myocarditis. Clin. Immunol. Immunopatho. 68, 159-69 (1993).
9. Hashimoto, I., Tatsumi, M. & Nakagawa, M. The role of T lymphocytes in the pathogenesis of Coxsackie virus B3 heart disease. Br. J. Exp. Pathol. 64, 497-504 (1983).
10. Henke, A., Huber, S., Stelzner, A. & Whitton, J.L. The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis. J. Virol. 69, 6720-6728 (1995).
11. Wolfgram, L.J., Beisel, K.W. & Rose, N.R. Heart-specific autoantibodies following murine coxsackievirus B3 myocarditis. J. Exp. Med. 161, 1112-1121 (1985).
12. Badorff, C. et al. Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nature Med. 5, 320-326 (1999).
13. Gauntt, C.J. et al. Anti-Coxsackievirus B3 neutralizing antibodies with pathological potential. Eur. Heart J. 12, 124-129 (1991).
14. Gauntt, C.J. et al. Epitopes shared between coxsackievirus B3 (CVB3) and normal heart tissue contribute to CVB3-induced murine myocarditis. Clin. Immunol. Immunopathol. 68, 129-134 (1993).
15. Sarvetnick, N., Liggitt, D., Pitts, S., Hansen, S. & Stewart, T. Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-γ. Cell 52, 773-782 (1988).
16. Gu, D.-L. & Sarvetnick, N. Epithelial cell proliferation and islet neogenesis in IFN-g transgenic mice. Development 118, 33-46 (1993).
17. Horwitz, M.S., Krahl, T., Fine, C., Lee, J. & Sarvetnick, N. Protection from lethal coxsackievirus-induced pancreatitis by expression of gamma interferon. J. Virol. 73, 1756-1766 (1999).
18. Rose, N.R., Wolfgram, L.J., Herskowitz, A. & Beisel, K.W. Postinfectious autoimmunity: two distinct phases of coxsackievirus B3-induced myocarditis. Ann. NY Acad. Sci. 475, 146-156 (1986).
19. Hohenadl, C., Klingel, K., Rieger, P., Hofschneider, P.H. & Kandolf, R. Investigation of the coxsackievirus B3 nonstructural proteins 2B, 2C, and 3AB: generation of specific polyclonal antisera and detection of replicating virus in infected tissue. J. Virol. Meth. 47, 279-295 (1994).
20. Schnurr, D.P., Cao, Y. & Schmidt, N.J. Coxsackievirus B3 persistence and myocarditis in N:NIH(S) II nu/nu and +/nu mice. J. Gen. Virol. 65, 1197-1201 (1984).
21. Lowenstein, C.J. et al. Nitric oxide inhibits viral replication in murine myocarditis. J. Clin. Invest. 97, 1837-1843 (1996).
22. Saura, M. et al. An antiviral mechanism of nitric oxide: inhibition of a viral protease. Immunity 10, 21-28 (1999).
23. Ramsingh, A.I., Lee, W.T., Collins, D.N. & Armstrong, L.E. T cells contribute to disease severity during coxsackievirus B4 infection. J. Virol. 73, 3080-3086 (1999).
24. Horwitz, M.S., Evans, C.F., McGavern, D.B., Rodriguez, M. & Oldstone, M.B.A. Primary demyelination in transgenic mice expressing interferon-γ. Nature Med. 3, 1037-1041 (1997).